Literature DB >> 10885657

Expression analysis of ataxin-7 mRNA and protein in human brain: evidence for a widespread distribution and focal protein accumulation.

K S Lindenberg1, G Yvert, K Müller, G B Landwehrmeyer.   

Abstract

Spinocerebellar ataxia 7 (SCA7) is an autosomal dominant neurodegenerative disorder caused by the expansion of a CAG-trinucleotide repeat in the coding region of the SCA7 gene. The expansion is translated into an extended polyglutamine stretch in the protein ataxin-7, a protein of unknown function. By Northern blot analysis expression of ataxin-7 was detected in numerous regions of human brain and some peripheral tissues. It is unknown, however, if ataxin-7 is enriched at sites of the SCA7 pathology. We studied the regional and cellular expression pattern of ataxin-7 at the mRNA level by in situ hybridization histochemistry in normal human brain. Furthermore we used a monoclonal and two polyclonal antibodies raised against the normal ataxin-7 to establish the distribution of this protein in brain, retina and peripheral organs. At the mRNA level ataxin-7 was preferentially expressed in neurons; the regional distribution reflected neuronal packing density. Ataxin-7 immunoreactivity (IR) was similarly widely expressed. In most neurons, ataxin-7 IR was preferentially localized to the cytoplasmatic compartment although some nuclear ataxin-7 IR was detected in most neurons. A more intense and more prominently nuclear ataxin-7 IR was observed in neurons of the pons and the inferior olive, brain regions severly affected by the disease, suggesting that the subcellular localization and abundance of ataxin-7 is regulated in a regionally specific way. Since neurons displaying more intense and more prominently nuclear ataxin-7 IR belonged to the class of susceptible cells in SCA7, an enrichment of normal ataxin-7 in the nuclear compartment may contribute to neurodegeneration. However not all sites of SCA7 pathology displayed a strong cytoplasmatic and nuclear immunoreactivity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10885657     DOI: 10.1111/j.1750-3639.2000.tb00270.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  14 in total

1.  Somatic instability of expanded CAG repeats of ATXN7 in Japanese patients with spinocerebellar ataxia type 7.

Authors:  Satoshi Katagiri; Takaaki Hayashi; Tomokazu Takeuchi; Hisashi Yamada; Tamaki Gekka; Kiyokazu Kawabe; Akira Kurita; Hiroshi Tsuneoka
Journal:  Doc Ophthalmol       Date:  2015-02-03       Impact factor: 2.379

2.  Differential degradation of full-length and cleaved ataxin-7 fragments in a novel stable inducible SCA7 model.

Authors:  Xin Yu; Abiodun Ajayi; Narasimha Rao Boga; Anna-Lena Ström
Journal:  J Mol Neurosci       Date:  2012-02-25       Impact factor: 3.444

3.  Ataxin-7 associates with microtubules and stabilizes the cytoskeletal network.

Authors:  Yoko Nakamura; Kazuhiko Tagawa; Tsutomu Oka; Toshikazu Sasabe; Hikaru Ito; Hiroki Shiwaku; Albert R La Spada; Hitoshi Okazawa
Journal:  Hum Mol Genet       Date:  2011-11-18       Impact factor: 6.150

4.  Polyglutamine-expanded spinocerebellar ataxia-7 protein disrupts normal SAGA and SLIK histone acetyltransferase activity.

Authors:  Stacey J McMahon; Marilyn G Pray-Grant; David Schieltz; John R Yates; Patrick A Grant
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-02       Impact factor: 11.205

Review 5.  The roles of proteolysis and nuclear localisation in the toxicity of the polyglutamine diseases. A review.

Authors:  R Walsh; E Storey; D Stefani; L Kelly; V Turnbull
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

Review 6.  Molecular Targets and Therapeutic Strategies in Spinocerebellar Ataxia Type 7.

Authors:  Anna Niewiadomska-Cimicka; Yvon Trottier
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

7.  Inhibition of autophagy via p53-mediated disruption of ULK1 in a SCA7 polyglutamine disease model.

Authors:  Xin Yu; Andrés Muñoz-Alarcón; Abiodun Ajayi; Kristin E Webling; Anne Steinhof; Ülo Langel; Anna-Lena Ström
Journal:  J Mol Neurosci       Date:  2013-04-18       Impact factor: 3.444

8.  Pontine atrophy precedes cerebellar degeneration in spinocerebellar ataxia 7: MRI-based volumetric analysis.

Authors:  O Y Bang; P H Lee; S Y Kim; H J Kim; K Huh
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-10       Impact factor: 10.154

Review 9.  Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration.

Authors:  Gwenn A Garden; Albert R La Spada
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

10.  Expanded ataxin-7 cause toxicity by inducing ROS production from NADPH oxidase complexes in a stable inducible Spinocerebellar ataxia type 7 (SCA7) model.

Authors:  Abiodun Ajayi; Xin Yu; Staffan Lindberg; Ulo Langel; Anna-Lena Ström
Journal:  BMC Neurosci       Date:  2012-07-24       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.